All 19 Nifty Pharma stocks, including Gland Pharma, Lupin, and Dr Reddy's, fell over 1% following Donald Trump's announcement of new drug tariffs. Investors reacted to concerns over reduced export revenues for Indian pharmaceutical companies. The Nifty Pharma index dropped 1.32% to 25,747.60 in early trading. This reflects long-term uncertainty for India's $25 billion pharma export sector facing US regulatory pressures.
All 19 Nifty Pharma stocks, including Gland Pharma, Lupin, and Dr Reddy's, fell over 1% following Donald Trump's announcement of new drug tariffs. Investors reacted to concerns over reduced export revenues for Indian pharmaceutical companies. The Nifty Pharma index dropped 1.32% to 25,747.60 in early trading. This reflects long-term uncertainty for India's $25 billion pharma export sector facing US regulatory pressures.